The notices it replaced
- Reissues: PAR-24-151 Translational Neural Devices (R61/R33 - Clinical Trial Optional)
- 2 steps back: RFA-NS-21-021 Translational Neural Devices (UG3/UH3 - Clinical Trial Optional)
- 3 steps back: RFA-NS-18-011 Translational Neural Devices (UG3/UH3 - Clinical Trial Required)
Who won it before
11 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $13,136,560 in first-year total cost, median $1,205,629.
Most frequent study sections
- Neurological Sciences and Disorders C Study Section[NSD-C]7
- Special Emphasis Panel[ZNS1 SRB-A (02)]1
- Special Emphasis Panel[ZNS1 SRB-C (12)]1
- Special Emphasis Panel[ZNS1 SRB-G (59)]1
- Special Emphasis Panel[ZNS1 SRB-T (32)]1
Most frequent institutions
- UNIVERSITY OF TEXAS DALLAS2
- BAYLOR COLLEGE OF MEDICINE1
- CASE WESTERN RESERVE UNIVERSITY1
- MAYO CLINIC ROCHESTER1
- REHABILITATION INSTITUTE OF CHICAGO D/B/A SHIRLEY RYAN ABILITYLAB1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Simplified, Scalable 24-hour adaptive deep brain stimulation for Parkinson’s disease1UG3NS140730-01 · under RFA-NS-21-021 | LITTLE, SIMONSTARR, PHILIP ANDREW | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $1,419,954 | NSD |
| 2024 | Stimulus-evoked directional field potentials to guide subthalamic and pallidal DBS for PD1UG3NS130202-01A1 · under RFA-NS-21-021 | WALKER, HARRISON CARROLL | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $1,232,410 | ZNS1 |
| 2024 | Enhancing recovery of lower limb function after spinal cord injury1UG3NS131971-01A1 · under RFA-NS-21-021 | HAYS, SETH ALANSONKILGARD, MICHAEL PRENNAKER, ROBERT LSWANK, CHAD DOUGLAS | UNIVERSITY OF TEXAS DALLAS, TX | $1,177,221 | NSD |
| 2023 | A Neuromusculoskeletal Interface for Bionic Arms: A Randomized Crossover Study1UG3NS127063-01A1 · under RFA-NS-21-021 | HARGROVE, LEVI JOHN | REHABILITATION INSTITUTE OF CHICAGO D/B/A SHIRLEY RYAN ABILITYLAB, IL | $1,205,629 | ZNS1 |
| 2022 | Minimally Invasive Cerebral Blood Flow and Oxygenation Monitoring for Intracranial Hypertension1UG3NS123191-01A1 · under RFA-NS-21-021 | FLOYD, THOMAS FREDERICK | UT SOUTHWESTERN MEDICAL CENTER, TX | $1,814,829 | NSD |
| 2022 | Intracranial multimodal physiological monitoring in acute brain injury1UG3NS123307-01 · under RFA-NS-18-011 | SCHIFF, STEVEN JSPENCER, DENNIS DZAVERI, HITTEN P | YALE UNIVERSITY, CT | $1,697,634 | NSD |
| 2022 | Multi-Center Clinical Trial of Spinal Cord Stimulation to Restore Cough1UG3NS121560-01A1 · under RFA-NS-18-011 | DIMARCO, ANTHONY F.MARTINS, TONY | CASE WESTERN RESERVE UNIVERSITY, OH | $1,608,519 | NSD |
| 2022 | Novel Stimulation Patterns to Improve the Effectiveness of Spinal Cord Stimulation1UG3NS121563-01A1 · under RFA-NS-18-011 | ESTELLER, ROSANAVISWANATHAN, ASHWIN | BAYLOR COLLEGE OF MEDICINE, TX | $1,056,085 | NSD |
| 2022 | AccelBand, a leg-worn transcutaneous neuromodulation device for treating neurogenic bowel dysfunction in individuals with spinal cord injury1UG3NS125182-01A1 · under RFA-NS-21-021 | CHEN, JIANDEMAENG, JIMINPIKOV, VICTORRODRIGUEZ, GIANNA MVOIT, WALTER | TRANSTIMULATION RESEARCH, INC., OK | $608,659 | ZNS1 |
| 2022 | Optimizing Pharmacotherapy with Noninvasive Wearable Sensors and Subscalp EEG1UG3NS123066-01 · under RFA-NS-18-011 | BRINKMANN, BENJAMIN HWORRELL, GREGORY A | MAYO CLINIC ROCHESTER, MN | $604,937 | NSD |
| 2019 | Wireless Nerve Stimulation Device To Enhance Recovery After Stroke1UG3NS109497-01 · under RFA-NS-18-011 | HAYS, SETH ALANSONRENNAKER, ROBERT L | UNIVERSITY OF TEXAS DALLAS, TX | $710,683 | ZNS1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.